115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 3 study of disitamab vedotin with pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001; trial in progress)
    Meeting Abstract

    Powles, T.; Grande, E.; Van Der Heijden, M.; Necchi, A.; Iyer, G.; Drakaki, A.; Loriot, Y.; Sokolowski, K.; Zhang, W.; Galsky, M.
    European Urology (2024)

    Fulltext@MSK | Save
  • Analysis of the Tumor MicroEnvironment (TME) in high-grade Ta (HG Ta) bladder cancer reveals an immune and stromal enriched subtype which demonstrates poor prognosis with concurrent carcinoma-in situ (CIS)
    Meeting Abstract

    Mark, F.; Jacob, T.; Pietzak, E.
    European Urology (2024)

    Fulltext@MSK | Save
  • Does the PRECISE score improves PI-RADS ability to predict grade reclassification in men on active surveillance for early prostate cancer?
    Meeting Abstract

    Leni, R.; Stabile, A.; Brembilla, G.; De Cobelli, F.; Gandaglia, G.; Zaurito, P.; Santangelo, A.; Viti, A.; Montorsi, F.; Vickers, A.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses
    Meeting Abstract

    Goleva, E.; Lacouture, M.; Lyubchenko, T.; Gu, S.; Xiao, O.; Kraehenbuehl, L.; Berdyshev, E.; Ketosugbo, K.; Moy, A.; Rotemberg, V.; more...
    Journal of Allergy and Clinical Immunology (2024)

    Fulltext@MSK | Save
  • Node positive non-clear cell renal cell carcinoma: Oncological outcomes and genomic insights
    Meeting Abstract

    Eismann, L.; Zucker, M.; Dawidek, M.; Reese, S.; Posada Calderon, L.; Aulitzky, A.; Stief, C.; Coleman, J.; Kotecha, R.; Carlo, M.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • The highest grade group does not drive the risk of advanced stage when systematic and multiparametric Magnetic Resonance Imaging (MRI)-targeted biopsies are discordant: Results from a large multi-institutional series
    Meeting Abstract

    Scuderi, S. L. A.; Tin, A.; Gaffney, C.; Bianchi, L.; Kesch, C.; Marra, G.; Soeterik, T.; Ploussard, G.; Ettala, O.; Stroomberg, H.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Do incidental prostate cancer patients managed with active surveillance exhibit different disease features and outcomes compared to their biopsy-diagnosed counterparts? Results of a multi-institutional study
    Meeting Abstract

    Leni, R.; Stabile, A.; Capitanio, U.; Roscigno, M.; La Croce, G.; Da Pozzo, L. F.; Olivier, J.; Zattoni, F.; Facco, M.; Dal Moro, F.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Development of a porcine model of bladder cancer using the Oncopig
    Meeting Abstract

    Aulitzky, A.; Vanden Berg, R. W.; Kim, K.; Al-Ahmadie, H.; Monette, S.; Shariat, S.; Coleman, J. A.
    European Urology (2024)

    Fulltext@MSK | Save
  • Molecular, immunohistochemical and clinical determinants of urothelial carcinoma of the bladder with nested subtype
    Meeting Abstract

    Koll, F. J.; Basar, M.; Chen, Z.; Tin, A. L.; Alam, S. M.; Tallman, J. E.; Clinton, T. N.; Whiting, K.; Chen, J. F.; Sarungbam, J.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • The quantification of GSP4 volume is superior to ISUP GG classification and %GSP4 for predicting adverse outcomes in radical prostatectomy patients
    Meeting Abstract

    Scuderi, S. L. A.; Tin, A.; Stabile, A.; Mazzone, E.; Quarta, L.; Zaurito, P.; Ciabattini, M.; Cosenza, A.; Brancaccio, M.; Leni, R.; more...
    European Urology (2024)

    Fulltext@MSK | Save